Methylphenidate does not improve cognitive function in healthy sleep-deprived young adults

Area of Science:

• Neuroscience
• Pharmacology
• Cognitive Psychology

Background:

• Methylphenidate, a treatment for attention-deficit/hyperactivity disorder (ADHD), is increasingly abused by students seeking cognitive enhancement.
• This study investigates the effects of methylphenidate on cognitive function in sleep-deprived individuals.

Purpose of the Study:

• To determine if methylphenidate improves cognitive performance in healthy young adults after 24 hours of sleep deprivation.
• To assess physiological changes, including blood pressure and heart rate, associated with methylphenidate use in this context.

Main Methods:

• Healthy young adults received either methylphenidate (20 mg) or a placebo after 24 hours of sleep deprivation.
• Cognitive function was assessed using standardized tests (Hopkins Verbal Learning, Digit Span, Modified Stroop, Trail Making).
• Physiological measures (blood pressure, heart rate) and plasma methylphenidate concentrations were monitored.

Main Results:

• No significant differences in cognitive test performance were observed between the methylphenidate and placebo groups.
• Methylphenidate administration led to increased systolic blood pressure and heart rate compared to placebo.
• Subjects receiving methylphenidate reported higher perceived "capsule effect" and confidence in their cognitive performance.

Conclusions:

• Methylphenidate does not enhance cognitive function in sleep-deprived young adults.
• Subjective improvements may be linked to increased confidence and sympathetic nervous system stimulation.
• Methylphenidate use can cause potentially harmful physiological effects.